Anders Boeck Jensen

Anders Boeck Jensen

Auto-generated profile, based on publicly available information

Anders Boeck Jensen

Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
T(The International IBD Genetics Consortium (IIBDGC)
The International IBD Genetics Consortium (IIBDGC)
DEDavid Ellinghaus
David Ellinghaus
I(International Genetics of Ankylosing Spondylitis Consortium (IGAS)
International Genetics of Ankylosing Spondylitis Consortium (IGAS)
I(International PSC Study Group (IPSCSG)
International PSC Study Group (IPSCSG)
G(Genetic Analysis of Psoriasis Consortium (GAPC)
Genetic Analysis of Psoriasis Consortium (GAPC)
AFAndre Franke
Andre Franke
David Ellinghaus and colleagues report a combined association analysis of five chronic inflammatory diseases. They identify 27 new associations and highlight disease-specific association patterns at shared susceptibility loci. We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.

24 June 2014 in Nature Communications
Verified
Journal Article
Open access
AJAnders Boeck Jensen
Anders Boeck Jensen
PMPope L. Moseley
Pope L. Moseley
TOTudor I. Oprea
Tudor I. Oprea
SESabrina Gade Ellesøe
Sabrina Gade Ellesøe
RERobert Eriksson
Robert Eriksson
SBSøren Brunak
Søren Brunak
A key prerequisite for precision medicine is the estimation of disease progression from the current patient state. Disease correlations and temporal disease progression (trajectories) have mainly been analysed with focus on a small number of diseases or using large-scale approaches without time consideration, exceeding a few years. So far, no large-scale studies have focused on defining a comprehensive set of disease trajectories. Here we present a discovery-driven analysis of temporal disease progression patterns using data from an electronic health registry covering the whole population of Denmark. We use the entire spectrum of diseases and convert 14.9 years of registry data on 6.2 million patients into 1,171 significant trajectories. We group these into patterns centred on a small number of key diagnoses such as chronic obstructive pulmonary disease (COPD) and gout, which are central to disease progression and hence important to diagnose early to mitigate the risk of adverse outcomes. We suggest such trajectory analyses may be useful for predicting and preventing future diseases of individual patients.

1 September 2013 in Cell
Verified
Journal Article
Closed access
DBDavid Blair
David Blair
CLChristopher S. Lyttle
Christopher S. Lyttle
JMJonathan M. Mortensen
Jonathan M. Mortensen
CBCharles F. Bearden
Charles F. Bearden
AJAnders Boeck Jensen
Anders Boeck Jensen
ARAndrey Rzhetsky
Andrey Rzhetsky

4 November 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBMette K. Beck
Mette K. Beck
AJAnders Boeck Jensen
Anders Boeck Jensen
ANAnnelaura Bach Nielsen
Annelaura Bach Nielsen
APAnders Perner
Anders Perner
PMPope L. Moseley
Pope L. Moseley
SBSøren Brunak
Søren Brunak
Sepsis affects millions of people every year, many of whom will die. In contrast to current survival prediction models for sepsis patients that primarily are based on data from within-admission clinical measurements (e.g. vital parameters and blood values), we aim for using the full disease history to predict sepsis mortality. We benefit from data in electronic medical records covering all hospital encounters in Denmark from 1996 to 2014. This data set included 6.6 million patients of whom almost 120,000 were diagnosed with the ICD-10 code: A41 ‘Other sepsis’. Interestingly, patients following recurrent trajectories of time-ordered co-morbidities had significantly increased sepsis mortality compared to those who did not follow a trajectory. We identified trajectories which significantly altered sepsis mortality, and found three major starting points in a combined temporal sepsis network: Alcohol abuse, Diabetes and Cardio-vascular diagnoses. Many cancers also increased sepsis mortality. Using the trajectory based stratification model we explain contradictory reports in relation to diabetes that recently have appeared in the literature. Finally, we compared the predictive power using 18.5 years of disease history to scoring based on within-admission clinical measurements emphasizing the value of long term data in novel patient scores that combine the two types of data.

15 February 2019 in Cancer Research
Verified
Journal Article
Open access
PDF file
JHJessica X. Hu
Jessica X. Hu
MHMarie Helleberg
Marie Helleberg
AJAnders B. Jensen
Anders B. Jensen
SBSøren Brunak
Søren Brunak
JLJens Lundgren
Jens Lundgren
Although many diseases are associated with cancer, the full spectrum of temporal disease correlations across cancer types has not yet been characterized. A population-wide study of longitudinal disease trajectories is needed to interrogate the general medical histories of patients with cancer. Here we performed a retrospective study covering a 20-year period, using 6.9 million patients from the Danish National Patient Registry linked to 0.7 million patients with cancer from the Danish Cancer Registry. Statistical analysis identified all significant disease associations occurring prior to cancer diagnoses. These associations were used to build frequently occurring, longitudinal disease trajectories. Across 17 cancer types, a total of 648 significant diagnoses correlated directly with a cancer, while 168 diagnosis trajectories of time-ordered steps were identified for seven cancer types. The most common diseases across cancer types involved cardiovascular, obesity, and genitourinary diseases. A comprehensive, publicly available web tool of interactive illustrations for all cancer disease associations is provided. By exploring the precancer landscape using this large dataset, we identify disease associations that can be used to derive mechanistic hypotheses for future cancer research. Significance: This study offers an innovative approach to examine prediagnostic disease and cancer development in a large national population-based setting and provides a publicly available tool to foster additional cancer surveillance research.

22 November 2016
Verified
Conference Paper
Open access
PDF file
MBMette K. Beck
Mette K. Beck
DWDavid Westergaard
David Westergaard
AJAnders Boeck Jensen
Anders Boeck Jensen
LGLeif Groop
Leif Groop
SBSøren Brunak
Søren Brunak
Most studies of disease etiologies focus on one disease only and not the full spectrum of multimorbidities that many patients have. Some disease pairs have shared causal origins, others represent common follow-on diseases, while yet other co-occurring diseases may manifest themselves in random order of appearance. We discuss these different types of disease co-occurrences, and use the two diseases "sleep apnea" and "diabetes" to showcase the approach which otherwise can be applied to any disease pair. We benefit from seven million electronic medical records covering the entire population of Denmark for more than 20 years. Sleep apnea is the most common sleep-related breathing disorder and it has previously been shown to be bidirectionally linked to diabetes, meaning that each disease increases the risk of acquiring the other. We confirm that there is no significant temporal relationship, as approximately half of patients with both diseases are diagnosed with diabetes first. However, we also show that patients diagnosed with diabetes before sleep apnea have a higher disease burden compared to patients diagnosed with sleep apnea before diabetes. The study clearly demonstrates that it is not only the diagnoses in the patient’s disease history that are important, but also the specific order in which these diagnosis are given that matters in terms of outcome. We suggest that this should be considered for patient stratification.